- In July 2021, Heron Therapeutics Inc., a U.S.-based company, launched ZYNRELEF, an extended-release product designed to provide postsurgical pain relief for up to 72 hours after procedures such as bunionectomy, inguinal hernia repair, or total knee replacement, targeting soft tissue and periarticular applications
- In June 2021, Bayer bolstered its presence in the Indian market by launching its Consumer Health division, aiming to enhance access to over-the-counter (OTC) health products. This move supports Bayer's strategy to expand its consumer health portfolio in key emerging markets such as India
- In January 2021, Eli Lilly & Co. finalized a licensing agreement with Japan's Asahi Kasei Pharma, allowing the U.S. based company to develop and commercialize Asahi Kasei's innovative therapies. The partnership is focused on advancing treatments in key therapeutic areas, benefiting patients globally
- In January 2021, Pfizer formed a partnership with Premier, a U.S.-based healthcare improvement company, to provide five essential medications to healthcare practitioners, aimed at addressing both immediate and long-term medication needs for various patient care interventions
- In May 2020, California-based Assertio Therapeutics, Inc. merged with Pennsylvania-based Zyla Life Sciences, forming an expanding commercial pharmaceutical company focused on neurology, inflammation, and pain management products
Frequently Asked Questions
The market is segmented based on Segmentation By Pain Type (Acute and Chronic), Drug Class (Nonsteroidal Anti-inflammatory Drug (NSAIDs), Opioids, Salicylates, and Others), Type (Prescription drugs and Over-the-counter (OTC) drugs), Application (Musculoskeletal Pain, Surgical And Trauma-Related Pain, Cancer Pain, Neuropathic Pain, Migraines, Obstetrical Pain, Fibromyalgia, Pain Due to Burns, Dental/Facial Pain, Pediatric Pain, and Others), Route of Administration (Oral, Parenteral, and Others), End-Users (Hospitals, Specialty Clinics, Homecare, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others) – Industry Trends and Forecast to 2031
.
The Global Analgesics Market size was valued at USD 53.72 USD Billion in 2023.
The Global Analgesics Market is projected to grow at a CAGR of 4.69% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
